Abstract
IntroductionGuidelines recommend clozapine for treatment-resistant schizophrenia. However, meta-analysis of aggregate data (AD) did not demonstrate higher efficacy of clozapine compared with other second-generation antipsychotics but found substantial heterogeneity between trials...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have